M&A Deal Summary |
|
|---|---|
| Date | 2022-01-28 |
| Target | Triad Life Sciences |
| Sector | Medical Products |
| Buyer(s) | Convatec |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1978 |
| Sector | Medical Products |
| Employees | 10,000 |
| Revenue | 2.3B USD (2024) |
Convatec is a medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. Convatec Group products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. Convatec was founded in 1978 and is based in London, England.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Medical Products M&A | 2 of 2 |
| Type: Add-on Acquisition M&A Deals | 2 of 2 |
| State: Tennessee M&A | 1 of 1 |
| Country: United States M&A | 2 of 2 |
| Year: 2022 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-08-06 |
Convatec Group - SensiCare and Aloe Vesta
United Kingdom Convatec Group Plc - SensiCare and Aloe Vesta provides skin health solutions focuseed on preventative care with its skincare products. |
Sell | $29M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-10-21 |
Convatec Group - Urine Measurement Products
Reading, United Kingdom Convatec Group's Urine Measurement Products are used for routine or post-operative drainage, collection, and measurement of urine output from critically ill patients in hospitals and intensive care units (ICUs). |
Sell | - |
